USFDA Approval Awaited By Glenmark Pharmaceuticals For 4-6 Products During This Year
The company had already got approvals for 8 products this year and awaits approval of 4-6 products from the US Food and Drug Administration.
The company had already got approvals for 8 products this year and awaits approval of 4-6 products from the US Food and Drug Administration.
Glenmark Pharma Chairman & MD Glenn Saldanha said: "We are excited about the progress of GBR 830, the first OX40 antagonist globally to successfully complete Phase 1 studies."
OX40 is a very well validated target with the potential to treat a wide array of autoimmune diseases, he added.
Glenmark�s Patent Plea For Skin Care Drug Rejected By The US District Court Of Delaware
The court came to the conclusion that Glenmark had infringed the 070 patent of the plaintiffs and ordered the judgment in favor of Bayer and other plaintiffs.
The court came to the conclusion that Glenmark had infringed the 070 patent of the plaintiffs and ordered the judgment in favor of Bayer and other plaintiffs.
Glenmark India Launches Teneligliptin for Management of Type 2 Diabetes
Teneligliptin is an advanced new third-generation oral anti-diabetic agent that suppresses' glucagon release and increases insulin to lower blood glucose levels.
Teneligliptin is an advanced new third-generation oral anti-diabetic agent that suppresses' glucagon release and increases insulin to lower blood glucose levels.
Glenmark Gets US Regulator's Nod for Cholesterol-Lowering Drug Ezetimibe
Glenmark has sole exclusivity on the drug for 180 days. However, they cannot launch it in the US immediately owing to an out of court settlement with Merck.
Glenmark has sole exclusivity on the drug for 180 days. However, they cannot launch it in the US immediately owing to an out of court settlement with Merck.
